CLINICAL_TRIALS
trial_result
· 2018-04-09
Clinical Trial Update: Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations [Phase 2]
Summary
Phase 2 study evaluating bioequivalence of polyvinylpyrrolidone (PVP) formulations used in the T.R.U.E. TEST fragrance mix and thimerosal allergens for patch te…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allerderm | Conditions: Dermatitis, Contact | Phase 2 | Status: COMPLETED | Results posted: 2018-04-09